Phase 2 Lung Adenocarcinoma Stage I Clinical Trials

2 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–2 of 2 trials

Recruiting

Phase 2

Neoadjuvant Furmonertinib Plus Bevacizumab or Furmonertinib Monotherapy for Resectable and Potentially Resectable Stage III-IVA EGFR Mutation-Positive Lung Adenocarcinoma

Lung Adenocarcinoma Stage IIILung Adenocarcinoma Stage IVEGFR Gene Mutation

Shanghai Pulmonary Hospital, Shanghai, China96 enrolled1 locationNCT05503667

Recruiting

Phase 2

Surgery With or Without Chemotherapy for Stage I NSCLC With Micropapillary Component ≥ 20%

TreatmentLung Adenocarcinoma Stage IChemotherapy, Adjuvant+1 more

Shanghai Pulmonary Hospital, Shanghai, China460 enrolled1 locationNCT03351842